Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T19:22:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T08:13:11.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-29T05:32:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page has updated the number of study locations from 284 to 283 and removed specific dates related to the study. Additionally, the locations listed have been modified, with Timisoara, Romania being removed and specific postal codes added for Ramat Gan, Israel and Ankara, Turkey.
    Difference
    0.9%
    Check dated 2025-05-12T22:56:35.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-28T15:21:49.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study evaluating trastuzumab deruxtecan for HER2-positive metastatic breast cancer, while adding new identifiers and descriptions related to the study's design and drug information.
    Difference
    13%
    Check dated 2025-04-21T10:58:18.000Z thumbnail image

Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.